![(R)-N-[2,3-DIHYDRO-1-[2-(2-METHYLPHENYL)-2-OXOETHYL]-2-OXO-5-PHENYL-1H-1,4-BENZODIAZEPIN-3-YL]-N'-(3-METHYLPHENYL)-UREA Structure](https://www.chemicalbook.com/CAS/GIF/145084-28-2.gif)
(R)-N-[2,3-DIHYDRO-1-[2-(2-METHYLPHENYL)-2-OXOETHYL]-2-OXO-5-PHENYL-1H-1,4-BENZODIAZEPIN-3-YL]-N'-(3-METHYLPHENYL)-UREA
- Product Name(R)-N-[2,3-DIHYDRO-1-[2-(2-METHYLPHENYL)-2-OXOETHYL]-2-OXO-5-PHENYL-1H-1,4-BENZODIAZEPIN-3-YL]-N'-(3-METHYLPHENYL)-UREA
- CAS145084-28-2
- CBNumberCB5302859
- MFC32H28N4O3
- MW516.59
- MDL NumberMFCD00917023
- MOL File145084-28-2.mol
- MSDS FileSDS
Chemical Properties
| Melting point | 187-190 °C |
| Boiling point | 735.4±60.0 °C(Predicted) |
| Density | 1.23±0.1 g/cm3(Predicted) |
| storage temp. | Store at RT |
| solubility | DMSO: soluble5mg/mL (clear solution) |
| form | powder |
| pka | 11.61±0.40(Predicted) |
| color | white to beige |
| optical activity | [α]/D -128 to -140 (c = 1, DCM) |
| FDA UNII | 772CP7W12N |
Safety
| Symbol(GHS) |
|
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301+P310 |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | 3 |